This report studies the global market size of Reverse Transcriptase in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Reverse Transcriptase in these regions. This research report categorizes the global Reverse Transcriptase market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA. Although it is very different from the normal process, reverse transcriptase is an important enzyme. It is needed for function in viruses, eukaryotes and prokaryotes. Reverse transcriptase enzymes in cells are involved in genetic diversity and in the process of aging in eukaryotic cells. In viruses, reverse transcriptase allows the virus to insert its DNA to the host cell's DNA, forcing the cell to make more viruses. This is good for the virus but bad for the host. In the last several years, global market of Reverse Transcriptase developed smoothly, with an average growth rate of 4.6 %. In 2016, global revenue of Reverse Transcriptase is nearly 260 million USD; the actual production is about 570 liter. The classification of Reverse Transcriptase includes MMLV Reverse Transcriptase and AMV Reverse Transcriptase; Moloney Murine Leukemia Virus (MMLV) Reverse Transcriptase is an RNA-directed DNA polymerase. This enzyme can synthesize a complementary DNA strand initiating from a primer using either RNA (cDNA synthesis) or single-stranded DNA as a template. And the sales proportion of MMLV Reverse Transcriptase in 2016 is about 80.9%. Reverse Transcriptase can be used for PCR, Sequencing and Cloning, PCR was the largest application segment in 2016, and the proportion is about 59.4%. The application used in cloning with the fastest growth rate. In 2017, the global Reverse Transcriptase market size was 270 million US$ and is forecast to 330 million US in 2025, growing at a CAGR of 2.6% from 2018. The objectives of this study are to define, segment, and project the size of the Reverse Transcriptase market based on company, product type, application and key regions. The various contributors involved in the value chain of Reverse Transcriptase include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Reverse Transcriptase include Thermo Fisher Promega Roche Agilent Takara Bio Qiagen Bio-Rad Fapon Biotech Toyobo Vazyme New England Biolabs Market Size Split by Type MMLV Reverse Transcriptase AMV Reverse Transcriptase Market Size Split by Application PCR Sequencing Cloning Market size split by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Reverse Transcriptase market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. To understand the structure of Reverse Transcriptase market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Reverse Transcriptase manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Reverse Transcriptase with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Reverse Transcriptase submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Reverse Transcriptase are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (L). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Reverse Transcriptase market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Reverse Transcriptase Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Reverse Transcriptase Market Size Growth Rate by Type 1.4.2 MMLV Reverse Transcriptase 1.4.3 AMV Reverse Transcriptase 1.5 Market by Application 1.5.1 Global Reverse Transcriptase
